Cinnamedrine
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391711This classification denotes an adrenergic agonist with the molecular formula C19H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y1245J8012, chemically known as benzenemethanol, alpha-(1-(methyl(3-phenyl-2-propenyl)amino)ethyl)- but generally known as cinnamedrine, which bears US NIH Compound Identifier 5370611. European Medicines Agency schedules Cinnamedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06301MIG. The term CINNAMEDRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). CINNAMEDRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinnamedrine under HS 29221980 and SITC 51461. As of Q4 2014, CINNAMEDRINE remains the US FDA Preferred Term for this commodity. Cinnamedrine bears US NLM identifiers UMLS ID C0055752 and NCI Concept Code C87468. SMILES: OC(C(N(C/C=C/C1CCCCC1)C)C)C1CCCCC1.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.